Chevy Chase Trust
SCMP

Chevy Chase Trust’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Chevy Chase Trust’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-16,677
Closed -$104K – 666
2013
Q3 		$104K Hold
16,677
– – ﹤0.01% 643
2013
Q2 		$110K Buy
+16,677
New +$132K ﹤0.01% 640

Other funds holding SCMP

VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
USAA
United Services Automobile Association San Antonio, Texas $851M AUM 5.13% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Chevy Chase Trust's SCMP Position: Q4 2013 in Review

Chevy Chase Trust sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q4 2013, closing a stake of 16,677 shares — an estimated $104K sold.

Chevy Chase Trust first reported a position in SCMP in Q2 2013 and held it in 2 quarters. The position peaked at $110K in Q2 2013. 74 funds tracked by Wall St. Rank hold SCMP as of Q4 2013.

  • Chevy Chase Trust reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q4 2013 after selling out during the quarter.
  • Chevy Chase Trust sold 16,677 Sucampo Pharmaceuticals, Inc. shares in Q4 2013, an estimated $104K.
  • Chevy Chase Trust first reported a position in Sucampo Pharmaceuticals, Inc. in Q2 2013 and held it in 2 quarters.
  • Chevy Chase Trust's Sucampo Pharmaceuticals, Inc. position peaked at $110K in Q2 2013.
  • 74 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q4 2013.

Based on Chevy Chase Trust's 13F filing for Q4 2013, filed 23 Jan 2014.